Topic outline

    • Welcome to the MSK Immuno-oncology for the Translational Researcher Short Course!


      The objective of the The Memorial Sloan Kettering Cancer Center (MSKCC) Immuno-oncology for the Translational Researcher Short Course (ITRSC) is to engage participants in an in-depth and participatory educational experience covering the topics relevant to clinical immunotherapy research and practice today: checkpoint blockade, novel immunomodulatory antibodies, cellular therapy, immune-monitoring, clinical trial design and development and points of integration with traditional cancer therapy.  

      Evaluation Participation Requirement:
      • Please take the mandatory Pre-course Assessment survey sent to you from oset@mskcc.org before the start of the course.
      • Follow up surveys are as follows:
        • Post-Course Assessment (Last Day of Course 3/22)
        • Six Month Assessment (Six months after course completion)
        • Twelve Month Assessment (Twelve months after course completion)

      Participants should check their email and junk email from oset@mskcc.org for the link to the appropriate survey.

      Course Information:
      • Pre-learning materials, calendar for each day & zoom links can be viewed at tabs above.
      • Course videos and slides can be accessed after 3/22/23 to participants that have completed the post-course assessment. 



      Questions? Contact us at oset@mskcc.org.


    • Page icon
      Tips-preparing for the course in Zoom Page
    • URL icon
      NASDC NCI Awardee Skills Homepage URL
    • Forum icon
      Announcements Forum